Latest Ratios: P/E Ratio 62.8x · EV/EBITDA 51.1x · ROE 38.0%. (2021–2024 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $42M | — | — | — | — |
| Enterprise Value | $42M | — | — | — | — |
| P/E Ratio → | 62.84 | — | — | — | — |
| P/S Ratio | 17.72 | — | — | — | — |
| P/B Ratio | 20.01 | — | — | — | — |
| P/FCF | 48.24 | — | — | — | — |
| P/OCF | 43.94 | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — |
| EV / EBITDA | 51.11 | — | — | — | — |
| EV / EBIT | 52.57 | — | — | — | — |
| EV / FCF | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 91.8% | 91.8% | 87.4% | 73.5% | 66.6% |
| Operating Margin | 33.3% | 33.3% | 48.0% | 10.3% | -53.8% |
| Net Profit Margin | 20.1% | 20.1% | 34.6% | 10.0% | -52.1% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | 38.0% | 38.0% | 146.6% | 127.3% | — |
| ROA | 17.9% | 17.9% | 35.6% | 12.3% | -81.6% |
| ROIC | 114.6% | 114.6% | 8595.4% | — | — |
| ROCE | 61.5% | 61.5% | 201.4% | 131.1% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.05 | 0.03 | 0.17 | — |
| Debt / EBITDA | 0.09 | 0.09 | 0.03 | 0.12 | — |
| Net Debt / Equity | — | -0.32 | -0.99 | -3.65 | — |
| Net Debt / EBITDA | -0.58 | -0.58 | -0.83 | -2.41 | — |
| Debt / FCF | — | -0.55 | -9.65 | -0.38 | — |
| Interest Coverage | — | — | — | 1015.59 | -419.58 |
Net cash position: cash ($547498) exceeds total debt ($70318)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | 1.87 | 1.87 | 1.75 | 0.96 | 0.41 |
| Quick Ratio | 1.82 | 1.82 | 1.67 | 0.92 | 0.14 |
| Cash Ratio | 0.36 | 0.36 | 0.83 | 0.24 | 0.06 |
| Asset Turnover | — | 0.77 | 1.09 | 0.76 | 1.57 |
| Inventory Turnover | 2.73 | 2.73 | 3.24 | 5.41 | 0.98 |
| Days Sales Outstanding | — | 170.05 | 105.50 | 290.13 | 31.25 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | 1.6% | — | — | — | — |
| FCF Yield | 2.1% | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | — | — | — | — |
| Shares Outstanding | — | $26M | $26M | $26M | $26M |
Geopolitical and Regulatory Exposure
Based on current market data, the company trades at a P/E of 62.84 and a P/S of 17.72, which suggests that investors are pricing in significant growth expectations that appear disconnected from the reported 3.14% year-over-year revenue decline observed in recent financial filings.
The valuation multiples imply a high-growth trajectory that is not currently supported by the company's top-line performance. Investors should monitor whether these elevated ratios reflect a mispricing of the brand's niche franchise model or if the market is anticipating a structural turnaround that has yet to materialize in the financials.
As reported in financial statements, the company maintains a robust 91.80% gross margin, yet the compression to a 33.32% operating margin suggests that significant SG&A expenditures are required to sustain the franchise-based distribution network, potentially limiting the scalability of the firm's current business model.
The wide gap between gross and operating margins indicates that the company's profitability is highly sensitive to the costs of maintaining its localized franchise relationships. This structure suggests that while the product itself commands premium pricing, the operational cost of supporting the distribution network may be a persistent drag on net profitability.
According to the company's balance sheet, the negligible 0.05% debt-to-equity ratio indicates a highly conservative capital structure, which provides a significant buffer against interest rate volatility but may also suggest a lack of aggressive reinvestment strategies to drive future expansion in the competitive Chinese skincare market.
The near-absence of debt reflects a risk-averse management approach that is well-suited for the regulatory uncertainties inherent in the Chinese personal care sector. However, this lack of leverage warrants further investigation into whether the company is missing opportunities to optimize its capital structure to enhance shareholder returns.
The P/E ratio is frequently misapplied to this business model because it fails to account for the high proportion of non-operating income or tax artifacts common in US-listed Chinese holding companies, which can artificially inflate the perceived earnings quality of the Park Ha brand.
Analysts should prioritize EV/EBITDA or cash-flow-based metrics over P/E to better strip away the noise created by the company's complex cross-border structure. Relying solely on P/E risks overestimating the sustainability of the company's net income, especially given the lack of transparency regarding the accessibility of cash held within Chinese subsidiaries.
Includes 30+ ratios · 4 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BYAH stock.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's current P/E ratio is 62.8x. This places it at the 50th percentile of its historical range.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's current EV/EBITDA is 51.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's return on equity (ROE) is 38.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 104.0%.
Based on historical data, Park Ha Biological Technology Co., Ltd. Ordinary Shares is trading at a P/E of 62.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has 91.8% gross margin and 33.3% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.